Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Balcar L; Carbonell-Asins JA; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M, 2025. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.  Hepatology 81(2):609-624

Hartl L; Schwarz M; Reiberger T, 2025. Letter: Insulin-Like Growth Factor-1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver-Related MortAlity-Authors' Reply.  Aliment Pharmacol Ther 61(3):595-596

Hartl L; Schwarz M; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Hofer BS; Dominik N; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2025. Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply.  Aliment Pharmacol Ther 61(1):228-229

Hartl L; Schwarz M; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Hofer BS; Dominik N; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2025. Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality.  Aliment Pharmacol Ther 61(1):88-98

Schwarz M; Schmidbauer VU; Malik J; Nowak NM; Kienast P; Watzenboeck M; Stuempflen M; Schwarz C; Kittinger J; Bettelheim D; Haberl C; Binder J; Kiss H; Reiberger T; Prayer D; Kasprian G, 2024. Intrauterine blood transfusion causes dose- and time-dependent signal alterations in the liver and the spleen on fetal magnetic resonance imaging.  Eur Radiol.

Schwarz M; Mozayani B; Trauner M; Stättermayer AF, 2024. Chronic hepatitis E in a patient after chimeric antigen receptor-T-cell treatment for diffuse large B-cell lymphoma and rapid progression towards decompensated liver cirrhosis.  Br J Haematol.

Bernhard J; Schwarz M; Balcar L; Hofer B; Dominik N; Strassl R; Aberle S; Munda P; Mandorfer M; Trauner M; Reiberger T; Jachs M, 2024. Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center.  Sci Rep 14(1):25921

Semmler G; Balcar L; Simbrunner B; Hartl L; Jachs M; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Gensluckner S; Scheiner B; Aigner E; Trauner M; Reiberger T; Mandorfer M, 2024. Diagnostic and prognostic performance of the LiverRisk score in tertiary care.  JHEP Rep 6(11):101169

Dominik N; Balcar L; Semmler G; Simbrunner B; Schwarz M; Hofer BS; Hartl L; Jachs M; Scheiner B; Pinter M; Trauner M; Mandorfer M; Pilger A; Reiberger T, 2024. Letter: Zinc and Selenium-Potential Biomarkers for Chronic Liver Disease? Authors' Reply.  Aliment Pharmacol Ther 60(10):1497-1498

Balcar L; Schwarz M; Dorn L; Jachs M; Hartl L; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Hind J; Wenisch C; Sebesta C; Wachter-Welzl J; Watzl P; Neuhauser M; Chromy D; Mandorfer M; Schmid D; Gschwantler M; Reiberger T; Maieron A; Bauer DJM; Schwarz C, 2024. A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project.  Liver Int 44(12):3151-3163

Schwarz M; Simbrunner B; Jachs M; Hartl L; Balcar L; Bauer DJM; Semmler G; Hofer BS; Scheiner B; Pinter M; Stättermayer AF; Trauner M; Reiberger T; Mandorfer M, 2024. High histamine levels are associated with acute-on-chronic liver failure and liver-related death in patients with advanced chronic liver disease.  Liver Int 44(11):2904-2914

Nixdorf L; Hartl L; Ströhl S; Felsenreich DM; Mairinger M; Jedamzik J; Richwien P; Mozayani B; Semmler G; Balcar L; Schwarz M; Jachs M; Dominik N; Bichler C; Trauner M; Mandorfer M; Reiberger T; Langer FB; Bauer DJM; Prager G, 2024. Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study.  Sci Rep 14(1):17558

Dominik N; Balcar L; Semmler G; Simbrunner B; Schwarz M; Hofer BS; Hartl L; Jachs M; Scheiner B; Pinter M; Trauner M; Mandorfer M; Pilger A; Reiberger T, 2024. Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease.  Aliment Pharmacol Ther 60(7):876-887

Pfisterer N; Schwarz M; Schwarz C; Putre F; Ritt L; Riedl F; Hartl L; Jachs M; Mandorfer M; Madl C; Trauner M; Reiberger T, 2024. Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.  PLoS One 19(6):e0302811

Burghart L; Ferenci P; Petrenko O; Mandorfer M; Schwarz M; Gschwantler M; Trauner M; Reiberger T; Stättermayer AF, 2024. Portal hypertension and its prognostic implications in patients with Wilson's disease.  Aliment Pharmacol Ther 60(2):257-266

Dominik N; Semmler G; Hartl L; Balcar L; Schwarz M; Hofer BS; Reiberger T; Bauer DJM, 2024. Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity-Authors' reply.  Aliment Pharmacol Ther 60(2):282-283

Bauer DJM; Nixdorf L; Dominik N; Schwarz M; Hofer BS; Hartl L; Semmler G; Jachs M; Simbrunner B; Jedamzik J; Mozayani B; Gensthaler L; Felsenreich DM; Trauner M; Langer FB; Mandorfer M; Prager G; Reiberger T, 2024. The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled study.  Aliment Pharmacol Ther 60(1):70-82

Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M, 2024. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.  J Hepatol 81(1):76-83

Dominik N; Scheiner B; Zanetto A; Balcar L; Semmler G; Campello E; Schwarz M; Paternostro R; Simbrunner B; Hofer BS; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Simioni P; Reiberger T; Mandorfer M, 2024. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.  Aliment Pharmacol Ther 59(11):1376-1386

Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B, 2024. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.  J Hepatol 81(2):248-257

Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M, 2024. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.  Hepatology 80(4):887-900

Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2024. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.  J Hepatol 80(5):744-752

Pfisterer N; Schwarz M; Madl C; Mandorfer M; Reiberger T, 2024. Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors' reply.  Hepatol Int 18(2):706-707

Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Dannenberg V; Trauner M; Mandorfer M; Reiberger T, 2024. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality.  JHEP Rep 6(1):100954

Schwarz C; Bauer D; Dorn L; Jachs M; Hartl L; Chromy D; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Schwarz M; Balcar L; Semmler G; Brinkmann L; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Kurteva V; Traugott M; Hind J; Wenisch C; Aburaia A; Sebesta C; Schmid D; Rothweiler S; Remetic J; Gschwantler M; Maieron A; Reiberger T, 2024. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria.  Wien Klin Wochenschr 136(9-10):278-288

Schwarz C; Schubert R; Schwarz M; Schütz A; Jenke A; Bauer D; Steinwender B; Gutic E; Reiberger T; Haltmayer H; Gschwantler M, 2023. CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers.  J Virus Erad 9(3):100338

Schwarz M; Schwarz C; Burghart L; Pfisterer N; Bauer D; Hübl W; Mandorfer M; Gschwantler M; Reiberger T, 2023. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.  PLoS One 18(8):e0290352

Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2023. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis.  JHEP Rep 5(8):100789

Jachs M; Panzer M; Hartl L; Schwarz M; Balcar L; Camp JV; Munda P; Mandorfer M; Trauner M; Aberle SW; Zoller H; Reiberger T; Ferenci P, 2023. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.  JHEP Rep 5(8):100751

Schwarz C; Schwarz M; Schmidbauer V; Kainberger F; Milos RI; Langenberger H; Gessl I; Funk G; Gschwantler M, 2023. Diffuse idiopathic skeletal hyperostosis as a cause for dysphagia in a patient with ankylosing spondylitis.  Wien Klin Wochenschr 135(11-12):311-315

Pfisterer N; Schwarz M; Jachs M; Putre F; Ritt L; Mandorfer M; Madl C; Trauner M; Reiberger T, 2023. Endoscopic band ligation is safe despite low platelet count and high INR.  Hepatol Int 17(5):1205-1214

Schwarz M; Schwarz C; Schütz A; Schwanke C; Krabb E; Schubert R; Liebich ST; Bauer D; Burghart L; Brinkmann L; Gutic E; Reiberger T; Haltmayer H; Gschwantler M, 2023. Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.  J Virus Erad 9(1):100319

Schwarz C; Chromy D; Bauer D; Duong N; Schmidbauer VU; Schwarz M; Mandorfer M; Rieger A; Trauner M; Gschwantler M; Reiberger T, 2023. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up.  Wien Klin Wochenschr 135(15-16):420-428

Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2023. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.  Clin Gastroenterol Hepatol 21(9):2318-2326.e7

Schwarz M; Schwarz C; Mossig E; Lampichler K; Schmidbauer V; Hofmann A; Langenberger H; Lagler H; Auer H; Gschwantler M, 2022. Isolated peritoneal involvement as a primary manifestation of cystic echinococcosis.  Lancet Infect Dis 22(12):1769

Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2022. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.  J Viral Hepat 29(12):1062-1072

Schwarz C; Chromy D; Bangert C; Schwarz M; Jachs M; Reiberger T; Gschwantler M, 2022. Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis.  J Hepatol 77(1):254-255

Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodríguez-Tajes S; Genescà J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2022. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.  J Hepatol 76(4):812-821

Schmidbauer C; Chromy D; Schmidbauer VU; Schwarz M; Jachs M; Bauer DJM; Binter T; Apata M; Nguyen DT; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Breuer M; Strassl R; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2021. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.  Liver Int 41(11):2622-2634

Schmidbauer C; Schwarz M; Schütz A; Schubert R; Schwanke C; Gutic E; Pirker R; Lang T; Reiberger T; Haltmayer H; Gschwantler M, 2021. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy.  PLoS One 16(6):e0252274

Publication list retrieved from NCBI using ImpactPubs